[HTML] plos.org

[HTML][HTML] Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - PloS one, 2022 - journals.plos.org
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …
被引用次数：25 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - PLoS ONE, 2022 - ncbi.nlm.nih.gov
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-a prospective cohort study.

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - 2022 - cabidigitallibrary.org
Background: Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study.

M Lampart, N Zellweger, S Bassetti… - PLoS …, 2022 - search.ebscohost.com
Background: Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study.

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - Plos one, 2022 - europepmc.org
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study

M Lampart, N Zellweger, S Bassetti… - PloS …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …
[PDF] researchgate.net

[PDF][PDF] Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti… - PLoS ONE, 2022 - researchgate.net
Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory
infections—A prospective coh Page 1 RESEARCH ARTICLE Clinical utility of inflammatory …
[PDF] scienceopen.com

[PDF][PDF] Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti… - PLoS ONE, 2022 - scienceopen.com
Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory
infections—A prospective coh Page 1 RESEARCH ARTICLE Clinical utility of inflammatory …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti… - PLoS …, 2022 - ui.adsabs.harvard.edu
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …